A core human primary tumor angiogenesis signature identifies the endothelial orphan receptor ELTD1 as a key regulator of angiogenesis

Cancer Cell

Volumn 24, Issue 2, 2013, Pages 229-241

  Masiero, Massimo ^a,b   Simões, FilipaCosta ^b,c   Han, HeeDong ^d   Snell, Cameron ^a   Peterkin, Tessa ^b   Bridges, Esther ^b   Mangala, LingegowdaS ^d   Wu, SherryYen Yao ^d   Pradeep, Sunila ^d   Li, Demin ^a   Han, Cheng ^b   Dalton, Heather ^d   Lopez Berestein, Gabriel ^d   Tuynman, JurriaanB ^a   Mortensen, Neil ^a   Li, Ji Liang ^b   Patient, Roger ^b   Sood, AnilK ^d   Banham, AlisonH ^a   Harris, AdrianL ^b   Buffa, FrancescaM ^b   more..

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR ELTD1; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; FEMALE; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 84881549640     PISSN: 15356108     EISSN: 18783686     Source Type: Journal    
DOI: 10.1016/j.ccr.2013.06.004     Document Type: Article

References (44)

1. Bais, C., Singh, M., Kaminker, J., and Brauer, M. May 2011. Biological markers for monitoring patient response to vegf antagonists. U.S. Patent 20,110,117,083.
2. Baldewijns M.M., van Vlodrop I.J., Vermeulen P.B., Soetekouw P.M., van Engeland M., de Bruïne A.P. VHL and HIF signalling in renal cell carcinogenesis. J.Pathol. 2010, 221:125-138.
3. Bjarnadóttir T.K., Fredriksson R., Höglund P.J., Gloriam D.E., Lagerström M.C., Schiöth H.B. The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. Genomics 2004, 84:23-33.
4. Bubendorf L., Nocito A., Moch H., Sauter G. Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput insitu studies. J.Pathol. 2001, 195:72-79.
5. Buffa F.M., Harris A.L., West C.M., Miller C.J. Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene. Br. J. Cancer 2010, 102:428-435.
6. Carmeliet P., Jain R.K. Molecular mechanisms and clinical applications of angiogenesis. Nature 2011, 473:298-307.
7. Carmeliet P., Jain R.K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 2011, 10:417-427.
8. Casadó V., Cortés A., Mallol J., Pérez-Capote K., Ferré S., Lluis C., Franco R., Canela E.I. GPCR homomers and heteromers: a better choice as targets for drug development than GPCR monomers?. Pharmacol. Ther. 2009, 124:248-257.
9. del Toro R., Prahst C., Mathivet T., Siegfried G., Kaminker J.S., Larrivee B., Breant C., Duarte A., Takakura N., Fukamizu A., et al. Identification and functional analysis of endothelial tip cell-enriched genes. Blood 2010, 116:4025-4033.
10. Dieterich L.C., Mellberg S., Langenkamp E., Zhang L., Zieba A., Salomäki H., Teichert M., Huang H., Edqvist P.H., Kraus T., et al. Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF-A and TGFβ2 in vascular abnormalization. J.Pathol. 2012, 228:378-390.
11. Duarte A., Hirashima M., Benedito R., Trindade A., Diniz P., Bekman E., Costa L., Henrique D., Rossant J. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev. 2004, 18:2474-2478.
12. Engelse M.A., Laurens N., Verloop R.E., Koolwijk P., van Hinsbergh V.W. Differential gene expression analysis of tubule forming and non-tubule forming endothelial cells: CDC42GAP as a counter-regulator in tubule formation. Angiogenesis 2008, 11:153-167.
13. Gale N.W., Dominguez M.G., Noguera I., Pan L., Hughes V., Valenzuela D.M., Murphy A.J., Adams N.C., Lin H.C., Holash J., et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc. Natl. Acad. Sci. USA 2004, 101:15949-15954.
14. Gering M., Rodaway A.R., Göttgens B., Patient R.K., Green A.R. The SCL gene specifies haemangioblast development from early mesoderm. EMBO J. 1998, 17:4029-4045.
15. Ghilardi C., Chiorino G., Dossi R., Nagy Z., Giavazzi R., Bani M. Identification of novel vascular markers through gene expression profiling of tumor-derived endothelium. BMC Genomics 2008, 9:201.
16. Han H.D., Mangala L.S., Lee J.W., Shahzad M.M., Kim H.S., Shen D., Nam E.J., Mora E.M., Stone R.L., Lu C., et al. Targeted gene silencing using RGD-labeled chitosan nanoparticles. Clin. Cancer Res. 2010, 16:3910-3922.
17. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
18. Hellström M., Phng L.K., Hofmann J.J., Wallgard E., Coultas L., Lindblom P., Alva J., Nilsson A.K., Karlsson L., Gaiano N., et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007, 445:776-780.
19. Herbert J.M., Stekel D., Sanderson S., Heath V.L., Bicknell R. A novel method of differential gene expression analysis using multiple cDNA libraries applied to the identification of tumour endothelial genes. BMC Genomics 2008, 9:153.
20. Isogai S., Lawson N.D., Torrealday S., Horiguchi M., Weinstein B.M. Angiogenic network formation in the developing vertebrate trunk. Development 2003, 130:5281-5290.
21. Krebs L.T., Shutter J.R., Tanigaki K., Honjo T., Stark K.L., Gridley T. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev. 2004, 18:2469-2473.
22. Kutschera S., Weber H., Weick A., De Smet F., Genove G., Takemoto M., Prahst C., Riedel M., Mikelis C., Baulande S., et al. Differential endothelial transcriptomics identifies semaphorin 3G as a vascular class 3 semaphorin. Arterioscler. Thromb. Vasc. Biol. 2011, 31:151-159.
23. Kwakkenbos M.J., Kop E.N., Stacey M., Matmati M., Gordon S., Lin H.H., Hamann J. The EGF-TM7 family: a postgenomic view. Immunogenetics 2004, 55:655-666.
24. Leslie J.D., Ariza-McNaughton L., Bermange A.L., McAdow R., Johnson S.L., Lewis J. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 2007, 134:839-844.
25. Li J.L., Harris A.L. Crosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implications. Front. Biosci. 2009, 14:3094-3110.
26. Li J.L., Sainson R.C., Oon C.E., Turley H., Leek R., Sheldon H., Bridges E., Shi W., Snell C., Bowden E.T., et al. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy invivo. Cancer Res. 2011, 71:6073-6083.
27. Liu T., Qian W.J., Gritsenko M.A., Camp D.G., Monroe M.E., Moore R.J., Smith R.D. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res. 2005, 4:2070-2080.
28. Lu C., Han H.D., Mangala L.S., Ali-Fehmi R., Newton C.S., Ozbun L., Armaiz-Pena G.N., Hu W., Stone R.L., Munkarah A., et al. Regulation of tumor angiogenesis by EZH2. Cancer Cell 2010, 18:185-197.
29. Nechiporuk T., Urness L.D., Keating M.T. ETL, a novel seven-transmembrane receptor that is developmentally regulated in the heart. ETL is a member of the secretin family and belongs to the epidermal growth factor-seven-transmembrane subfamily. J.Biol. Chem. 2001, 276:4150-4157.
30. Phng L.K., Gerhardt H. Angiogenesis: a team effort coordinated by notch. Dev. Cell 2009, 16:196-208.
31. Sana T.R., Janatpour M.J., Sathe M., McEvoy L.M., McClanahan T.K. Microarray analysis of primary endothelial cells challenged with different inflammatory and immune cytokines. Cytokine 2005, 29:256-269.
32. Seaman S., Stevens J., Yang M.Y., Logsdon D., Graff-Cherry C., St Croix B. Genes that distinguish physiological and pathological angiogenesis. Cancer Cell 2007, 11:539-554.
33. Siekmann A.F., Lawson N.D. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007, 445:781-784.
34. St Croix B., Rago C., Velculescu V., Traverso G., Romans K.E., Montgomery E., Lal A., Riggins G.J., Lengauer C., Vogelstein B., Kinzler K.W. Genes expressed in human tumor endothelium. Science 2000, 289:1197-1202.
35. Sumanas S., Jorniak T., Lin S. Identification of novel vascular endothelial-specific genes by the microarray analysis of the zebrafish cloche mutants. Blood 2005, 106:534-541.
36. Towner R.A., Jensen R.L., Colman H., Vaillant B., Smith N., Casteel R., Saunders D., Gillespie D.L., Silasi-Mansat R., Lupu F., et al. ELTD1, a potential new biomarker for gliomas. Neurosurgery 2013, 72:77-90. discussion 91.
37. Uhlen M., Oksvold P., Fagerberg L., Lundberg E., Jonasson K., Forsberg M., Zwahlen M., Kampf C., Wester K., Hober S., et al. Towards a knowledge-based Human Protein Atlas. Nat. Biotechnol. 2010, 28:1248-1250.
38. van Beijnum J.R., Griffioen A.W. In silico analysis of angiogenesis associated gene expression identifies angiogenic stage related profiles. Biochim. Biophys. Acta 2005, 1755:121-134.
39. van Beijnum J.R., Dings R.P., van der Linden E., Zwaans B.M., Ramaekers F.C., Mayo K.H., Griffioen A.W. Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature. Blood 2006, 108:2339-2348.
40. Wallgard E., Larsson E., He L., Hellström M., Armulik A., Nisancioglu M.H., Genove G., Lindahl P., Betsholtz C. Identification of a core set of 58 gene transcripts with broad and specific expression in the microvasculature. Arterioscler. Thromb. Vasc. Biol. 2008, 28:1469-1476.
41. Weber G.J., Choe S.E., Dooley K.A., Paffett-Lugassy N.N., Zhou Y., Zon L.I. Mutant-specific gene programs in the zebrafish. Blood 2005, 106:521-530.
42. Xiao J., Jiang H., Zhang R., Fan G., Zhang Y., Jiang D., Li H. Augmented cardiac hypertrophy in response to pressure overload in mice lacking ELTD1. PLoS ONE 2012, 7:e35779.
43. Xiong J.W., Yu Q., Zhang J., Mably J.D. An acyltransferase controls the generation of hematopoietic and endothelial lineages in zebrafish. Circ. Res. 2008, 102:1057-1064.
44. Yao X., Qian C.N., Zhang Z.F., Tan M.H., Kort E.J., Yang X.J., Resau J.H., Teh B.T. Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin. Cancer Res. 2007, 13:161-169.